Case Reports in Oncological Medicine

Case Reports in Oncological Medicine / 2012 / Article

Case Report | Open Access

Volume 2012 |Article ID 402798 | https://doi.org/10.1155/2012/402798

K. Daoudi, K. El Haoudi, N. Bouyahia, A. Benlemlih, S. Arifi, N. Mellas, K. Mazaz, A. Amarti, O. El Mesbahi, "Signet Ring Cell Carcinoma of the Vater's Ampulla: A Very Rare Malignancy", Case Reports in Oncological Medicine, vol. 2012, Article ID 402798, 2 pages, 2012. https://doi.org/10.1155/2012/402798

Signet Ring Cell Carcinoma of the Vater's Ampulla: A Very Rare Malignancy

Academic Editor: Y.-J. Chen
Received31 Jul 2012
Accepted28 Aug 2012
Published26 Sep 2012

Abstract

Most tumors affecting Vater's ampulla are adenocarcinomas, and other histological variants are less frequent. Signet ring cell carcinoma is more commonly found in the stomach than at other sites of the digestive system. Signet ring cell carcinoma of the Vater’s ampulla is extremely rare, and only 15 cases have previously been described in the literature. It mainly occurs in elderly patients (median ag years). We report a case of advanced signet ring cell carcinoma of the ampulla of Vater, with invasion of the duodenum (D3) admitted in the Medical Oncology Unit of HASSAN II University Hospital.

1. Introduction

Tumors of the ampulla of Vater are not common [1]. Ampulla of Vater cancers are usually well differentiated adenocarcinomas [2].

Signet-ring cell carcinoma (SRCC) usually occurs in the gastrointestinal tract. The World Health Organization (WHO) defines it as a special type or a variant of gastrointestinal adenocarcinoma. SRCs may exist alone or coexist with any other types of malignant gastrointestinal tumors. SRCC is very rarely found among carcinomas of the ampulla of Vater [3].

Here, we present new case with advanced SRCC in the ampulla of Vater, and we analyse different data about diagnosis, possible etiology, and treatment of this entity.

2. Case Presentation

We report the case of a 55-year-old man, without pathological antecedents, admitted with jaundice and abdominal pain appearing 6 months ago.

Abdominal ultrasound showed dilatation of the common bile duct and the intrahepatic bile ducts.

Abdominal computed tomography and Bili-IRM showed a tumor in the ampulla of Vater with invasion of D3 and a dilatation of the extra hepatic bile duct; no loco regional lymph nodes were observed.

Duodenoscopy showed irregularly shaped erosion on the ampulla of Vater and histology of the biopsy revealed a poorly differentiated signet ring cell carcinoma.

A cephalic duodenopancreatectomy and extended lymphadenectomy were performed.

The definitive histological study showed a signet ring cell carcinoma of the Vater’s ampulla with negative resection margins.

Postoperative thoraco-abdomino-pelvic computed tomography, CA19-9, and CEA were normal.

The tumor was classified as pT3 N0 M0.

6 cycles of adjuvant chemotherapy based on CISPLATIN + GEMCITABINE were performed with good clinical tolerance and nonfebrile neutropenia grade 3 after the second cycle.

The patient remained well and had no evidence of loco regional and metastatic recurrence during the 8 months of followup.

3. Discussion

SRCC can arise in many organs, but it usually occurs in the gastrointestinal tract, especially in the stomach. It has been reported that 90% of SRCC occurs in the stomach, with the rest arising in several other organs, including the breast, gallbladder, pancreas, urinary bladder, and colon [4].

It is extremely uncommon in the ampulla of Vater. Less than 15 cases have been described in the literature.

The presence of this kind of tumor has no clear histological explanation.

Two possible theories have been proposed: the presence of gastric heterotopia in the ampulla of Vater or the existence of a perivaterian duodenal heterotopia of ulcerous etiology as the origin of a signet ring cell tumor which secondarily invades the ampulla of Vater [4].

Akatsu et al. [5] have summarized the previous 14 cases (eight men and six women) and concluded that the median age at diagnosis was 57 years (range, 32–83 years), approximately 15 years older than SRCC of the stomach, but similar to the median age for SRCC of the large bowel.

Hara et al. [6] report the case of seven patients presented SRCC of the Vater’s ampulla. The mean age of the published cases was 60.3 years (range: 25–72 years). Jaundice was the most common symptom (5 out of 7 patients); the macroscopic appearance was superficial protruding (4 cases), ulcerative (2 cases), or diffuse infiltrative (1 case). The treatment was duodenopancreatectomy in six patients and local excision in one high-risk surgical patient. None of the resected patients had lymph node involvement.

According to the TNM classification, they were divided between T3N0M0 (5 cases), T2N0M0 (1 case), and TxNxM0 (1 case).

The present patient had the typical characteristics of other cases in terms of age, jaundice, macroscopic appearance, treatment approach, and TNM classification.

For diagnosis of SRCC, helical computed tomography (CT) shows a dilated CBD (common bile duct) without a mass lesion in the ampulla of Vater in some cases [79].

In our case, abdominal computed tomography showed a tumor in the ampulla of Vater with invasion of D3 and a dilatation of the extra hepatic bile duct.

Contrast-enhanced ultrasound (CEUS) has gained increasing interest in recent years. By CEUS, the lesion may be displayed much clearer than by conventional gray-scale ultrasound. It can also offer a good method in the discrimination of ampullary carcinoma from nonmalignant lesions [10].

As for prognosis, signet ring cell tumors localized in other digestive organs have a poor prognosis. The scant number of cases reported in the ampulla precludes any conclusions about survival associated with this histological variant.

But lymph node involvement is a determinant prognostic factor in cancer of the ampulla of Vater [6].

Duodenopancreatectomy with pylorus preservation is the treatment of choice in ampullar cancers [6]. Adjuvant therapy has not showed survival benefit in patients without lymph node infiltration [2].

4. Conclusion

In conclusion, we have presented a rare case of signet ring cell carcinoma in the ampulla of Vater with invasion of the duodenum. Although several cases have been reported, the detailed clinicopathological features and prognosis are not clear. Additional reports are warranted.

Supplementary Materials

Figure 1: CT scan of the abdomen cut showed a process in the ampulla of Vater.

Figure 2: The tumor was solely formed by signet ring cell carcinoma.

  1. Supplementary Figures

References

  1. T. Kamisawa, M. Fukayama, M. Koike et al., “Carcinoma of the ampulla of Vater: expression of cancer-associated antigens inversely correlated with prognosis,” American Journal of Gastroenterology, vol. 83, no. 10, pp. 1118–1123, 1988. View at: Google Scholar
  2. J. M. Ramia, A. Mansilla, J. Villar, K. Muffak, D. Garrote, and J. A. Ferron, “Signet ring cell carcinoma of the Vater's ampulla,” Journal of the Pancreas, vol. 5, no. 6, pp. 495–497, 2004. View at: Google Scholar
  3. Y. Ishibashi, Y. Ito, K. Omori, and K. Wakabayashi, “Signet ring cell carcinoma of the ampulla of Vater. A case report,” Journal of the Pancreas, vol. 10, no. 6, pp. 690–693, 2009. View at: Google Scholar
  4. T. Yokota, Y. Kunii, S. Teshima et al., “Signet ring cell carcinoma of the stomach: a clinicopathological comparison with the other histological types,” Tohoku Journal of Experimental Medicine, vol. 186, no. 2, pp. 121–130, 1998. View at: Google Scholar
  5. T. Akatsu, K. Aiura, S. Takahashi, K. Kameyama, M. Kitajima, and Y. Kitagawa, “Signet-ring cell carcinoma of the ampulla of Vater: report of a case,” Surgery Today, vol. 37, no. 12, pp. 1110–1114, 2007. View at: Publisher Site | Google Scholar
  6. T. Hara, H. Kawashima, M. Ishigooka, M. Kashiyama, S. Takanashi, and Y. Hosokawa, “Signet-ring-cell carcinoma of the ampulla of Vater: a case report,” Hepato-Gastroenterology, vol. 49, no. 44, pp. 561–563, 2002. View at: Google Scholar
  7. M. Bloomston, M. Walker, and W. L. Frankel, “Radical resection in signet ring carcinoma of the ampulla of Vater: report of an 11-year survivor,” American Surgeon, vol. 72, no. 2, pp. 193–195, 2006. View at: Google Scholar
  8. L. Li, Q. H. Chen, J. D. Sullivan, and F. U. Breuer, “Case report: signet-ring cell carcinoma of the ampulla of Vater,” Annals of Clinical and Laboratory Science, vol. 34, no. 4, pp. 471–475, 2004. View at: Google Scholar
  9. N. Eriguchi, S. Aoyagi, and A. Jimi, “Signet-ring cell carcinoma of the ampulla of Vater: report of a case,” Surgery Today, vol. 33, no. 6, pp. 467–469, 2003. View at: Publisher Site | Google Scholar
  10. J. M. Gao, S. S. Tang, W. Fu, and R. Fan, “Signet-ring cell carcinoma of ampulla of Vater: contrast-enhanced ultrasound findings,” World Journal of Gastroenterology, vol. 15, no. 7, pp. 888–891, 2009. View at: Publisher Site | Google Scholar

Copyright © 2012 K. Daoudi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views1336
Downloads500
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.